MYOMO, INC.

MYO

MYOMO, INC.

MYO

Insider Sentiment (TTM):

Last Purchase:2026-06-05Last Sale:2026-05-28Shares Purchased (TTM):303,690Shares Sold (TTM):101,767

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:12,539,116Shares Outstanding:42,269,133Institutional Ownership Pct.:29.66%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	11	11	14	13	14	20	24	7	6	5	7	7
Short Term Investments	2	4	4	0	1	4	0	0	3	6	2	4
Accounts Receivable Net Current	5	5	4	5	7	5	4	4	3	2	2	3
Inventory Net	3	4	3	4	4	3	3	3	3	2	2	1
Prepaid Expense And Other Assets Current	3	2	2	1	1	2	1	1	1	1	1	1
Assets Current	25	26	28	23	28	31	33	15	15	16	14	16
Restricted Cash	1	1	1	0	0	0	0	0	-	-	0	-
Operating Lease Right Of Use Asset	7	6	7	7	7	7	8	0	1	1	1	1
Investments In Affiliates Subsidiaries Associates …	-	-	-	-	-	-	-	-	-	-	0	0
Property Plant And Equipment Net	2	2	2	4	3	2	1	1	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	35	37	39	34	39	41	42	16	16	17	15	17
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	8	7	6	7	8	10	9	6	6	5	5	5
Operating Lease Liability Current	1	1	0	0	0	1	1	0	0	0	0	0
Taxes Payable Current	1	1	1	0	0	0	0	0	0	0	0	-
Deferred Income Current	0	0	0	0	0	0	0	0	0	0	0	0
Derivative Liabilities Current	1	1	1	-	-	-	0	-	-	-	-	-
Liabilities Current	11	9	8	9	12	12	10	7	6	6	5	6
Operating Lease Liability Noncurrent	7	7	8	8	8	8	7	0	0	0	0	0
Deferred Revenue Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Long Term Debt	12	11	11	2	1	-	0	-	-	-	-	-
Liabilities	30	28	27	19	21	19	18	7	7	6	6	6
Commitments And Contingencies	0	0	0	0	-	0	0	0	0	0	0	0
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	131	131	130	129	129	128	128	112	111	112	106	106
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	-0	-0	0	0	0	0	-0
Retained Earnings Accumulated Deficit	-126	-122	-119	-115	-111	-107	-103	-103	-102	-101	-97	-94
Treasury Stock Value	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Stockholders Equity	6	9	11	15	18	22	25	9	10	11	9	11
Liabilities And Stockholders Equity	35	37	39	34	39	41	42	16	16	17	15	17
Long Term Debt Current	0	3	3	1	0	-	3	-	-	-	-	-
Lines Of Credit Current	-	-	-	1	3	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	100	65	65	65	65	65	65	65	65	65	65	65
Common Stock Shares Issued	40	39	38	38	38	34	34	30	30	29	27	27
Shares Outstanding	40	39	38	38	38	34	34	30	30	29	27	27
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	25.00%	18.12%	11.24%	-	-	-	-	-	-	-	-	-
2025	-38.64%	-53.31%	-56.40%	-43.30%	-45.97%	-47.39%	13.41%	7.96%	-8.51%	-17.39%	10.97%	34.40%
2024	-13.23%	-18.32%	24.43%	6.67%	-7.14%	-10.48%	34.45%	52.39%	44.50%	4.32%	17.03%	-28.78%
2023	-	-	-	23.01%	60.64%	57.74%	89.20%	184.66%	85.23%	2.51%	7.52%	20.06%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.31	2.73	3.30	2.49	2.39	2.66	3.22	2.10	2.34	2.83	2.49	2.78
Quick Ratio	1.73	2.19	2.69	1.94	1.92	2.24	2.82	1.48	1.78	2.28	2.05	2.36
Working Capital	13.92M	16.27M	19.21M	13.75M	16.29M	19.42M	22.62M	7.71M	8.68M	10.15M	8.17M	10.26M
Leverage & Debt
Debt to Equity	5.06	3.08	2.39	1.33	1.20	0.88	0.71	0.76	0.67	0.52	0.62	0.55
Interest Coverage TTM	-6.54	-10.32	-13.74	-31.39	-20.95	-13.11	-15.97	-19.67	-20.43	-20.58	-20.06	-23.39
Debt Ratio	0.84	0.76	0.70	0.57	0.54	0.47	0.41	0.43	0.40	0.34	0.38	0.35
Efficiency & Turnover
Asset Turnover TTM	1.17	1.06	1.01	1.65	1.49	1.35	1.15	1.51	1.43	1.29	1.56	1.27
Days Sales Outstanding TTM	50.62	42.02	35.32	39.54	42.90	29.99	34.81	45.17	36.03	30.17	40.58	40.51
Receivables Turnover TTM	7.21	8.69	10.33	9.23	8.51	12.17	10.49	8.08	10.13	12.10	8.99	9.01
Per Share Metrics
Diluted EPS TTM	-0.34	-0.36	-0.37	-0.29	-0.22	-0.14	-0.16	-0.22	-0.25	-0.25	-0.28	-0.22
Free Cash Flow Per Share TTM	-0.25	-0.42	-0.45	-0.33	-0.28	-0.11	-0.12	-0.25	-0.25	-0.21	-0.21	-0.18
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	68.35%	65.96%	65.70%	66.56%	69.24%	71.18%	71.23%	70.03%	67.35%	67.39%	68.51%	68.63%
Operating Profit Margin TTM	-27.05%	-34.07%	-35.19%	-28.51%	-22.85%	-15.11%	-19.07%	-33.26%	-44.82%	-48.34%	-42.78%	-43.28%
Net Profit Margin TTM	-33.53%	-36.69%	-38.05%	-28.86%	-22.87%	-15.05%	-19.00%	-33.22%	-44.75%	-47.77%	-42.34%	-42.40%
Growth Metrics
Net Revenue Growth (1Y)	6.14%	6.68%	25.73%	64.99%	93.07%	97.60%	69.17%	36.23%	21.22%	29.17%	23.70%	19.18%
Net Income Growth (1Y)	55.60%	160.07%	151.85%	43.37%	-1.30%	-37.75%	-24.10%	6.73%	9.14%	-11.48%	-24.00%	-34.14%
EPS Growth (1Y)	51.54%	155.06%	127.20%	29.03%	-11.30%	-44.81%	-40.71%	-0.82%	-18.25%	-41.72%	-81.83%	-86.81%
Valuation Metrics
P/E TTM	-3.06	-1.89	-2.45	-3.13	-9.63	-34.30	-39.32	-18.15	-12.70	-12.87	-18.14	-4.98
P/B TTM	7.62	3.17	3.34	2.57	5.10	9.19	9.84	16.38	12.39	11.03	16.44	3.55
P/S TTM	1.03	0.69	0.93	0.90	2.20	5.16	7.47	6.03	5.68	6.15	7.68	2.11
Market Cap	44.41M	28.57M	38.09M	37.61M	89.82M	199.40M	243.17M	152.18M	119.95M	120.18M	147.79M	39.15M
Enterprise Value	44.72M	28.10M	35.18M	28.48M	79.41M	179.60M	221.75M	145.56M	114.11M	114.75M	140.92M	32.23M
Calculated Values
Free Cash Flow TTM	-10.80M	-17.91M	-18.73M	-13.85M	-11.74M	-4.69M	-4.65M	-9.54M	-9.50M	-7.76M	-6.32M	-6.40M
Net Debt	313.04K	-470.22K	-2.91M	-9.14M	-10.41M	-19.79M	-21.42M	-6.62M	-5.85M	-5.43M	-6.87M	-6.91M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-05Purchase

Owner: Kirk, Thomas F

Title: -

Shares: 40,002

Price/Share: $1.27

Value: $50,802.54

Shares Owned: 693,865

Relationship: Director

Ownership: Direct

2026-05-28Purchase

Owner: Kirk, Thomas F

Title: -

Shares: 25,000

Price/Share: $0.99

Value: $24,750.00

Shares Owned: 653,863

Relationship: Director

Ownership: Direct

2026-05-28Sale

Owner: Kovelman, Harry

Title: Chief Medical Officer

Shares: 11,536

Price/Share: $1.02

Value: $11,766.72

Shares Owned: 108,618

Relationship: Officer

Ownership: Direct

2026-05-18Purchase

Owner: Kirk, Thomas F

Title: -

Shares: 43,401

Price/Share: $0.91

Value: $39,494.91

Shares Owned: 628,863

Relationship: Director

Ownership: Direct

2026-05-15Purchase

Owner: Manko, Joseph M. Jr.

Title: -

Shares: 30,367

Price/Share: $0.89

Value: $27,026.63

Shares Owned: 2,309,775

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-05	Kirk, Thomas F	Director	-	Direct	Purchase	40,002	1.27	$50,802.54	693,865	4
2026-05-28	Kirk, Thomas F	Director	-	Direct	Purchase	25,000	0.99	$24,750.00	653,863	4
2026-05-28	Kovelman, Harry	Officer	Chief Medical Officer	Direct	Sale	11,536	1.02	$11,766.72	108,618	4
2026-05-18	Kirk, Thomas F	Director	-	Direct	Purchase	43,401	0.91	$39,494.91	628,863	4
2026-05-15	Manko, Joseph M. Jr.	Director	-	Indirect	Purchase	30,367	0.89	$27,026.63	2,309,775	4
2026-05-14	Mitchell, Micah	Officer	Chief Commercial Officer	Direct	Sale	90,231	0.86	$77,598.66	109,478	4/A
2026-03-16	Getz, Heather C	Director	-	Direct	Purchase	20,000	0.70	$14,000.00	131,754	4
2026-03-13	Kirk, Thomas F	Director	-	Direct	Purchase	72,000	0.71	$51,120.00	553,857	4
2026-03-12	Getz, Heather C	Director	-	Direct	Purchase	70,000	0.73	$51,100.00	111,754	4
2025-11-21	Kirk, Thomas F	Director	-	Direct	Purchase	2,535	0.72	$1,825.20	481,857	4
2025-11-19	Crowley, Thomas Aloysius …	Director	-	Indirect	Purchase	385	0.77	$296.45	479	4
2025-08-25	Kirk, Thomas F	Director	-	Direct	Purchase	50,000	1.15	$57,500.00	474,420	4
2025-08-18	Kirk, Thomas F	Director	-	Direct	Purchase	50,000	1.10	$55,000.00	424,420	4
2025-08-15	Gudonis, Paul R	Director,Officer	Chief Executive Officer	Direct	Purchase	50,000	0.95	$47,500.00	1,259,013	4
2025-05-15	Gudonis, Paul R	Director,Officer	Chief Executive Officer	Direct	Purchase	30,000	3.22	$96,600.00	1,051,671	4
2025-05-15	Kirk, Thomas F	Director	-	Direct	Purchase	36,824	3.25	$119,678.00	344,700	4
2025-05-14	Mitchell, Micah	Officer	Chief Commercial Officer	Direct	Sale	90,231	0.86	$77,598.66	109,478	4
2025-05-12	Kirk, Thomas F	Director	-	Direct	Purchase	50,000	3.35	$167,500.00	305,933	4
2025-03-14	Mitchell, Micah	Officer	Chief Commercial Officer	Direct	Sale	48,000	5.16	$247,680.00	140,269	4/A
2025-03-13	Kirk, Thomas F	Director	-	Direct	Purchase	7,400	5.00	$37,000.00	255,933	4
2025-03-12	Kovelman, Harry	Officer	Chief Medical Officer	Direct	Sale	30,000	5.50	$165,000.00	97,973	4
2024-09-05	Kovelman, Harry	Officer	Chief Medical Officer	Direct	Sale	6,700	3.76	$25,192.00	123,556	4
2024-09-03	Kovelman, Harry	Officer	Chief Medical Officer	Direct	Sale	2,029	4.01	$8,136.29	130,395	4
2024-05-29	Kirk, Thomas F	Director	-	Direct	Purchase	50,000	3.50	$175,000.00	236,499	4
2024-05-15	Kovelman, Harry	Officer	Chief Medical Officer	Direct	Sale	35,426	3.69	$130,721.94	98,009	4
2024-03-14	Kirk, Thomas F	Director	-	Direct	Purchase	50,000	3.50	$175,000.00	186,499	4
2023-12-08	Crowley, Thomas Aloysius …	Director	-	Direct	Sale	14,997	-	-	29,994	4
2023-12-01	Kovelman, Harry	Officer	Chief Medical Officer	Direct	Sale	8,333	-	-	140,854	4
2023-11-28	Crowley, Thomas Aloysius …	Director	-	Direct	Sale	14,997	-	-	45,001	4
2023-11-20	Kirk, Thomas F	Director	-	Direct	Purchase	50,000	3.10	$155,000.00	136,499	4
2023-09-08	Morris, Milton Mayo	Director	-	Direct	Purchase	15,000	1.06	$15,900.00	77,933	4
2023-08-30	Gudonis, Paul R	Director,Officer	Chief Executive Officer	Direct	Purchase	48,400	0.74	$35,816.00	878,245	4
2023-08-29	Henry, David A	Officer	Chief Financial Officer	Direct	Purchase	41,666	0.60	$24,999.60	352,193	4
2023-08-29	Gudonis, Paul R	Director,Officer	Chief Executive Officer	Direct	Purchase	37,000	0.78	$28,860.00	829,845	4
2023-08-29	Kovelman, Harry	Officer	Chief Medical Officer	Direct	Purchase	8,333	0.60	$4,999.80	149,556	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

29.66%

Inst. Shares: 12,539,116

Shares Outstanding: 42,269,133

2025-12-31

33.24%

Inst. Shares: 13,911,642

Shares Outstanding: 41,855,607

2025-09-30

32.16%

Inst. Shares: 13,559,485

Shares Outstanding: 42,168,120

2025-06-30

44.98%

Inst. Shares: 18,704,149

Shares Outstanding: 41,582,737

2025-03-31

37.50%

Inst. Shares: 15,544,840

Shares Outstanding: 41,454,472

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	12,539,116	42,269,133	29.66%
2025-12-31	13,911,642	41,855,607	33.24%
2025-09-30	13,559,485	42,168,120	32.16%
2025-06-30	18,704,149	41,582,737	44.98%
2025-03-31	15,544,840	41,454,472	37.50%
2024-12-31	14,347,819	37,758,837	38.00%
2024-09-30	9,718,315	37,950,515	25.61%
2024-06-30	11,496,730	37,368,488	30.77%
2024-03-31	9,653,924	36,752,597	26.27%
2023-12-31	9,241,604	29,499,341	31.33%
2023-09-30	6,076,192	35,266,361	17.23%
2023-06-30	3,372,012	27,992,928	12.05%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MYOMO, INC. (MYO) — SEC Financial Statements & Analysis

MYOMO, INC. (MYO) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. MYOMO, INC. trades on NYSE as: MYO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MYOMO, INC. reported a 6.14% year-over-year revenue growth, a Gross Profit Margin of 68.35% (TTM), a Debt-to-Equity ratio of 5.06x, a Price-to-Sales (P/S) ratio of 1.03x (TTM), a Price-to-Book (P/B) ratio of 7.62x (TTM), at a market cap of $44.41M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 6.14%
Gross Profit Margin TTM: 68.35%
Debt To Equity: 5.06x
P/S TTM: 1.03x
P/B TTM: 7.62x
Market Cap: $44.41M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MYOMO, INC. in?

MYOMO, INC. (MYO) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is MYO's market cap?

MYOMO, INC. (MYO) has a market capitalization of $44.41M as of 2026-06-30.

What exchange does MYO trade on?

MYOMO, INC. (MYO) trades on the NYSE.

Where is MYOMO, INC. incorporated?

MYOMO, INC. is incorporated in DE.

MYOMO, INC.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

MYOMO, INC. (MYO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

Wall Street's data.
Main Street's price.

MYOMO, INC. (MYO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.